Commentary & Perspectives

Why AI, Cloud & Sustainability Strategies May Collide 

UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK

Share

Digital transformation in UK pharmaceutical manufacturing is being challenged by simultaneous but conflicting initiatives, such as AI adoption, cloud migration, and sustainability goals. By 2026, these overlapping priorities may create operational friction, leading to stalled digital programs despite strong intentions and investments. Successful project replications often falter due to excessive customization at individual sites, which hampers scalability. Additionally, the hidden costs of data processing and AI usage on sustainability will require manufacturers to rethink their strategies for data management and operational efficiency.

Original Source(s)

Why AI, Cloud & Sustainability Strategies May Collide 

UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK

  • by Martyn Williams

  • February 16, 2026

  • 5 min

Related Content

When Inflammation Fuels Cancer in the IBD Colon

Researchers identify immune pathways that link long-term inflammation to tumor development

  • February 9, 2026

  • 3 min
The Unexpected Risks of Liquid Nitrogen Ingestion 

A case report describes gastric perforation following ingestion of a liquid nitrogen–infused drink 

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection